Integrated Cancer Genomics Division Archives

TGen-US Oncology data helps triple-negative breast cancer patients

by in Bioscience | Featured | Healthcare

Genomic sequencing has revealed therapeutic drug targets for difficult-to-treat, metastatic triple-negative breast cancer (TNBC), according to an unprecedented study by the Translational Genomic Research Institute (TGen) and US Oncology Research. The study is published by the journal Molecular Cancer Therapeutics and is currently available online. By sequencing, or spelling out, the billions of letters contained… Read More →